In this study, we further demonstrate that treatment with high doses of PL can activate caspase 8-initiated apoptotic signalling in both AR-expressing (LNCaP) and AR-null (PC3) prostate cancer cells. The gene discussed is CASP8; the disease is prostate carcinoma.